{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T02:14:32Z","timestamp":1648606472824},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T00:00:00Z","timestamp":1458518400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00393-016-0063-9","type":"journal-article","created":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T12:00:13Z","timestamp":1458561613000},"page":"284-291","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Aktuelle Therapie der polyartikul\u00e4ren Verlaufsform der juvenilen idiopathischen Arthritis"],"prefix":"10.1007","volume":"75","author":[{"given":"A.","family":"Hospach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"R\u00fchlmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Weller-Heinemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,21]]},"reference":[{"issue":"2","key":"63_CR1","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE et al (2004) International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31(2):390\u2013392","journal-title":"J Rheumatol"},{"issue":"5","key":"63_CR2","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s00393-011-0808-4","volume":"70","author":"HI Huppertz","year":"2011","unstructured":"Huppertz HI (2011) New criteria for the classification of rheumatoid arthritis: significance for child and adolescent rheumatology? Z Rheumatol 70(5):372\u2013374","journal-title":"Z Rheumatol"},{"issue":"7","key":"63_CR3","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/rheumatology\/ken085","volume":"47","author":"N Adib","year":"2008","unstructured":"Adib N et al (2008) Association between duration of symptoms and severity of disease at first presentation to paediatric rheumatology: results from the Childhood Arthritis Prospective Study. Rheumatology (Oxford) 47(7):991\u2013995","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"63_CR4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0049-0172(96)80009-6","volume":"26","author":"KG Oen","year":"1996","unstructured":"Oen KG, Cheang M (1996) Epidemiology of chronic arthritis in childhood. Semin Arthritis Rheum 26(3):575\u2013591","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"63_CR5","first-page":"645","volume":"31","author":"AG Greenwald","year":"2013","unstructured":"Greenwald AG et al (2013) Later-onset rheumatoid factor negative polyarticular juvenile idiopathic arthritis (JIA): a unique patient group? Clin Exp Rheumatol 31(4):645\u2013652","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"63_CR6","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/art.22709","volume":"56","author":"RK Saurenmann","year":"2007","unstructured":"Saurenmann RK et al (2007) Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor. Arthritis Rheum 56(6):1974\u20131984","journal-title":"Arthritis Rheum"},{"issue":"4","key":"63_CR7","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/art.23532","volume":"59","author":"M Twilt","year":"2008","unstructured":"Twilt M et al (2008) Long-term followup of temporomandibular joint involvement in juvenile idiopathic arthritis. Arthritis Rheum 59(4):546\u2013552","journal-title":"Arthritis Rheum"},{"key":"63_CR8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1546-0096-12-9","volume":"12","author":"T Hospach","year":"2014","unstructured":"Hospach T et al (2014) Cervical spine involvement in patients with juvenile idiopathic arthritis \u2013 MRI follow-up study. Pediatr Rheumatol Online J 12:9","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"63_CR9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/rheumatology\/kes054","volume":"52","author":"M Elhai","year":"2013","unstructured":"Elhai M et al (2013) Radiological cervical spine involvement in young adults with polyarticular juvenile idiopathic arthritis. Rheumatology (Oxford) 52(2):267\u2013275","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"63_CR10","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/rheumatology\/kep144","volume":"48","author":"S Ringold","year":"2009","unstructured":"Ringold S et al (2009) Inactive disease in polyarticular juvenile idiopathic arthritis: current patterns and associations. Rheumatology (Oxford) 48(8):972\u2013977","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"63_CR11","first-page":"545","volume":"30","author":"BM Ansell","year":"1983","unstructured":"Ansell BM (1983) Juvenile chronic arthritis with persistently positive tests for rheumatoid factor (sero-positive juvenile rheumatoid arthritis). Ann Pediatr (Paris) 30(8):545\u2013550","journal-title":"Ann Pediatr (Paris)"},{"issue":"4","key":"63_CR12","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/art.20952","volume":"52","author":"LE Schanberg","year":"2005","unstructured":"Schanberg LE et al (2005) Pain, stiffness, and fatigue in juvenile polyarticular arthritis: contemporaneous stressful events and mood as predictors. Arthritis Rheum 52(4):1196\u20131204","journal-title":"Arthritis Rheum"},{"issue":"6","key":"63_CR13","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaapos.2008.03.007","volume":"12","author":"K Sabri","year":"2008","unstructured":"Sabri K et al (2008) Course, complications, and outcome of juvenile arthritis-related uveitis. J AAPOS 12(6):539\u2013545","journal-title":"J AAPOS"},{"issue":"11","key":"63_CR14","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/S0161-6420(01)00773-4","volume":"108","author":"K Kotaniemi","year":"2001","unstructured":"Kotaniemi K et al (2001) Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study. Ophthalmology 108(11):2071\u20132075","journal-title":"Ophthalmology"},{"issue":"6","key":"63_CR15","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/rheumatology\/kem053","volume":"46","author":"A Heiligenhaus","year":"2007","unstructured":"Heiligenhaus A et al (2007) Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology (Oxford) 46(6):1015\u20131019","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"63_CR16","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.3899\/jrheum.130302","volume":"40","author":"ST Angeles-Han","year":"2013","unstructured":"Angeles-Han ST et al (2013) Risk markers of juvenile idiopathic arthritis-associated uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. J Rheumatol 40(12):2088\u20132096","journal-title":"J Rheumatol"},{"issue":"3","key":"63_CR17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3109\/09273948.2013.791701","volume":"21","author":"A Heiligenhaus","year":"2013","unstructured":"Heiligenhaus A et al (2013) Review for disease of the year: epidemiology of juvenile idiopathic arthritis and its associated uveitis: the probable risk factors. Ocul Immunol Inflamm 21(3):180\u2013191","journal-title":"Ocul Immunol Inflamm"},{"issue":"9","key":"63_CR18","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/art.38741","volume":"66","author":"H Schmeling","year":"2014","unstructured":"Schmeling H et al (2014) Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German Biologics JIA Registry. Arthritis Rheumatol 66(9):2580\u20132589","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"63_CR19","first-page":"585","volume":"30","author":"K Oen","year":"2003","unstructured":"Oen K et al (2003) Early predictors of longterm outcome in patients with juvenile rheumatoid arthritis: subset-specific correlations. J Rheumatol 30(3):585\u2013593","journal-title":"J Rheumatol"},{"issue":"8","key":"63_CR20","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/rheumatology\/kes019","volume":"51","author":"K Minden","year":"2012","unstructured":"Minden K et al (2012) Long-term outcome of patients with JIA treated with etanercept, results of the biologic register JuMBO. Rheumatology (Oxford) 51(8):1407\u20131415","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"63_CR21","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00393-014-1398-8","volume":"73","author":"HI Huppertz","year":"2014","unstructured":"Huppertz HI, Lehmann HW (2014) Evidence of treatment of chronic inflammation in childhood and adolescence with biologics. Z Rheumatol 73(10):907\u2013916","journal-title":"Z Rheumatol"},{"key":"63_CR22","volume-title":"Textbook of pediatric rheumatology","author":"T Beukelman","year":"2016","unstructured":"Beukelman T, Brunner H et al (2016) Chapter\u00a06. In: Petty R, Laxer R (Hrsg) Textbook of pediatric rheumatology. Elsevier, Philadelphia"},{"issue":"10","key":"63_CR23","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1136\/annrheumdis-2014-205372","volume":"74","author":"J Guzman","year":"2015","unstructured":"Guzman J et al (2015) The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort. Ann Rheum Dis 74(10):1854\u20131860","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"63_CR24","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.clim.2011.10.003","volume":"142","author":"G Dueckers","year":"2012","unstructured":"Dueckers G et al (2012) Evidence and consensus based GKJR guidelines for the treatment of juvenile idiopathic arthritis. Clin Immunol 142(2):176\u2013193","journal-title":"Clin Immunol"},{"issue":"4","key":"63_CR25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20460","volume":"63","author":"T Beukelman","year":"2011","unstructured":"Beukelman T et al (2011) American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken) 63(4):465\u2013482","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"63_CR26","unstructured":"Niehues T (2011) Leitlinien AWMF Register Nr.\u00a0027\/020"},{"issue":"13","key":"63_CR27","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1001\/jama.294.13.1671","volume":"294","author":"PJ Hashkes","year":"2005","unstructured":"Hashkes PJ, Laxer RM (2005) Medical treatment of juvenile idiopathic arthritis. JAMA 294(13):1671\u20131684","journal-title":"JAMA"},{"issue":"9","key":"63_CR28","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.3899\/jrheum.120110","volume":"39","author":"T Beukelman","year":"2012","unstructured":"Beukelman T et al (2012) Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: a cross-sectional analysis of the CARRA Registry. J Rheumatol 39(9):1867\u20131874","journal-title":"J Rheumatol"},{"issue":"16","key":"63_CR29","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM199204163261602","volume":"326","author":"EH Giannini","year":"1992","unstructured":"Giannini EH et al (1992) Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children\u2019s Study Group. N Engl J Med 326(16):1043\u20131049","journal-title":"N Engl J Med"},{"issue":"1","key":"63_CR30","first-page":"179","volume":"31","author":"K Alsufyani","year":"2004","unstructured":"Alsufyani K et al (2004) The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate. J Rheumatol 31(1):179\u2013182","journal-title":"J Rheumatol"},{"issue":"7","key":"63_CR31","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/art.20288","volume":"50","author":"N Ruperto","year":"2004","unstructured":"Ruperto N et al (2004) A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis Rheum 50(7):2191\u20132201","journal-title":"Arthritis Rheum"},{"issue":"3","key":"63_CR32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/ard.2007.075895","volume":"67","author":"A C\u00e9spedes-Cruz","year":"2008","unstructured":"C\u00e9spedes-Cruz A et al (2008) Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis. Ann Rheum Dis 67(3):309\u2013314","journal-title":"Ann Rheum Dis"},{"key":"63_CR33","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/art.24087","volume":"61","author":"HM Albers","year":"2009","unstructured":"Albers HM (2009) Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis. Arthritis Rheum 61:46\u201351","journal-title":"Arthritis Rheum"},{"issue":"12","key":"63_CR34","first-page":"2444","volume":"24","author":"HA Savolainen","year":"1997","unstructured":"Savolainen HA et al (1997) Azathioprine in patients with juvenile chronic arthritis: a longterm followup study. J Rheumatol 24(12):2444\u20132450","journal-title":"J Rheumatol"},{"key":"63_CR35","first-page":"118","volume":"13","author":"TK Kvien","year":"1986","unstructured":"Kvien TK, Hoyeraal HM, Sandstad B (1986) Azathioprine versus placebo in patients with juvenile rheumatoid arthritis: a single center double blind comparative study. J Rheumatol 13:118\u2013123","journal-title":"J Rheumatol"},{"issue":"5","key":"63_CR36","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3899\/jrheum.120715","volume":"40","author":"JR Curtis","year":"2013","unstructured":"Curtis JR et al (2013) Clinical response within 12 weeks as a predictor of future low disease activity in early RA patients: results from the TEAR Trial. J Rheumatol 40(5):572\u2013578","journal-title":"J Rheumatol"},{"issue":"16","key":"63_CR37","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMoa041810","volume":"352","author":"E Silverman","year":"2005","unstructured":"Silverman E et al (2005) Leflunomide or methotrexate for juvenile rheumatoid arthritis. N Engl J Med 352(16):1655\u20131666","journal-title":"N Engl J Med"},{"key":"63_CR38","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/acr.22259","volume":"66","author":"S Ringold","year":"2014","unstructured":"Ringold S et al (2014) Childhood arthritis and rheumatology research alliance consensus treatment plans for new onset polyarticular juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 66:1063\u20131072","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"63_CR39","first-page":"2696","volume":"27","author":"W Breit","year":"2000","unstructured":"Breit W et al (2000) A subgroup-specific evaluation of the efficacy of intraarticular triamcinolone hexacetonide in juvenile chronic arthritis. J Rheumatol 27(11):2696\u20132702","journal-title":"J Rheumatol"},{"issue":"10","key":"63_CR40","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s00296-011-2062-0","volume":"31","author":"HI Huppertz","year":"2011","unstructured":"Huppertz HI et al (2011) Progress in pediatric rheumatology: apprehend the opportunities of the future without forgetting the lessons from the past. Rheumatol Int 31(10):1259\u20131262","journal-title":"Rheumatol Int"},{"issue":"9","key":"63_CR41","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/acr.20521","volume":"63","author":"HI Huppertz","year":"2011","unstructured":"Huppertz HI (2011) Recommendations for juvenile idiopathic arthritis by the American College of Rheumatology: comment on the article by Beukelman et\u00a0al. Arthritis Care Res (Hoboken) 63(9):1354\u20131355 (author reply 1355\u20131356)","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"63_CR42","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM200003163421103","volume":"342","author":"DJ Lovell","year":"2000","unstructured":"Lovell DJ et al (2000) Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 342(11):763\u2013769","journal-title":"N Engl J Med"},{"issue":"5","key":"63_CR43","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/art.23427","volume":"58","author":"DJ Lovell","year":"2008","unstructured":"Lovell DJ et al (2008) Safety\u00a0and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis. Arthritis Rheum 58(5):1496\u20131504","journal-title":"Arthritis Rheum"},{"issue":"1","key":"63_CR44","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/rheumatology\/keq292","volume":"50","author":"V Papsdorf","year":"2011","unstructured":"Papsdorf V, Horneff G (2011) Complete control of disease activity and remission induced by treatment with etanercept in juvenile idiopathic arthritis. Rheumatology (Oxford) 50(1):214\u2013221","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"63_CR45","first-page":"688","volume":"26","author":"S Nielsen","year":"2008","unstructured":"Nielsen S et al (2008) Preliminary evidence that etanercept may reduce radiographic progression in juvenile idiopathic arthritis. Clin Exp Rheumatol 26(4):688\u2013692","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"63_CR46","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/ard.2007.087593","volume":"68","author":"G Horneff","year":"2009","unstructured":"Horneff G et al (2009) Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry. Ann Rheum Dis 68(4):519\u2013525","journal-title":"Ann Rheum Dis"},{"key":"63_CR47","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1002\/art.34458","volume":"64","author":"T Beukelman","year":"2012","unstructured":"Beukelman T et al (2012) Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum 64:2773\u20132780","journal-title":"Arthritis Rheum"},{"issue":"9","key":"63_CR48","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1093\/cid\/cit489","volume":"57","author":"SS Toussi","year":"2013","unstructured":"Toussi SS et al (2013) Infections in children and adolescents with juvenile idiopathic arthritis and inflammatory bowel disease treated with tumor necrosis factor-\u03b1 inhibitors: systematic review of the literature. Clin Infect Dis 57(9):1318\u20131330","journal-title":"Clin Infect Dis"},{"issue":"8","key":"63_CR49","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1546-0096-8-18","volume":"14","author":"P McCroskery","year":"2010","unstructured":"McCroskery P et al (2010) Summary of worldwide pediatric malignancies reported after exposure to etanercept. Pediatr Rheumatol Online J 14(8):18\u201326","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"63_CR50","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/art.34348","volume":"64","author":"T Beukelman","year":"2012","unstructured":"Beukelman T et al (2012) Rates of malignancy associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum 64(4):1263\u20131271","journal-title":"Arthritis Rheum"},{"issue":"12","key":"63_CR51","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1002\/art.27741","volume":"62","author":"JF Simard","year":"2010","unstructured":"Simard JF et al (2010) Juvenile idiopathic arthritis and risk of cancer: a nationwide cohort study. Arthritis Rheum 62(12):3776\u20133782","journal-title":"Arthritis Rheum"},{"issue":"8","key":"63_CR52","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa0706290","volume":"359","author":"DJ Lovell","year":"2008","unstructured":"Lovell DJ et al (2008) Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med 359(8):810\u2013820","journal-title":"N Engl J Med"},{"key":"63_CR53","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1002\/art.38569","volume":"66","author":"H Brunner","year":"2014","unstructured":"Brunner H, Ruperto N, Tzaribachev N et al (2014) A148: a multi-center, doubleblind, randomized-withdrawal trial of subcutaneous golimumab in pediatric patients with active polyarticular course juvenile idiopathic arthritis despite methotrexate therapy: week 48 results. Arthritis Rheum 66:S191\u2013S192","journal-title":"Arthritis Rheum"},{"issue":"9636","key":"63_CR54","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(08)60998-8","volume":"372","author":"N Ruperto","year":"2008","unstructured":"Ruperto N et al (2008) Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial. Lancet 372(9636):383\u2013391","journal-title":"Lancet"},{"issue":"6","key":"63_CR55","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/annrheumdis-2014-205351","volume":"74","author":"HI Brunner","year":"2015","unstructured":"Brunner HI et al (2015) Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial. Ann Rheum Dis 74(6):1110\u20131117","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"63_CR56","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/annrheumdis-2011-200598","volume":"71","author":"D Holzinger","year":"2012","unstructured":"Holzinger D et al (2012) The Toll-like receptor 4 agonist MRP8\/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis. Ann Rheum Dis 71(6):974\u2013980","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"63_CR57","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/ar4213","volume":"15","author":"JF Swart","year":"2013","unstructured":"Swart JF, de Roock S, Wulffraat NM (2013) What are the immunological consequences of long-term use of biological therapies for juvenile idiopathic arthritis? Arthritis Res Ther 15(3):213","journal-title":"Arthritis Res Ther"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-016-0063-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-016-0063-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-016-0063-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T16:37:31Z","timestamp":1559061451000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-016-0063-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,21]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["63"],"URL":"https:\/\/doi.org\/10.1007\/s00393-016-0063-9","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,21]]}}}